Susquehanna maintains a 'Positive' rating on WuXi PharmaTech (NYSE: WX), lowers price target to from $16 to $8.

Susquehanna ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE